BioCryst Pharma outlines designs for two BCX9930 trials as oral monotherapy for PNH patients
July 15 2021 - 7:21AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
BioCryst Pharmaceuticals (NASDAQ:BCRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioCryst Pharmaceuticals (NASDAQ:BCRX)
Historical Stock Chart
From Apr 2023 to Apr 2024